Galapagos NV
GLPG
#4857
Rank
A$2.72 B
Marketcap
A$40.53
Share price
1.12%
Change (1 day)
5.83%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : A$12.35 Million

According to Galapagos NV's latest financial reports the company's total debt is A$12.35 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$19.61 M25.95%
2023-12-31A$15.57 M-54.9%
2022-12-31A$34.52 M-17.72%
2021-12-31A$41.95 M-10.89%
2020-12-31A$47.08 M15.93%
2019-12-31A$40.61 M
2018-12-31N/A-100%
2017-12-31A$0.01 M-84.95%
2016-12-31A$0.09 M-46.74%
2015-12-31A$0.17 M-30.45%
2014-12-31A$0.24 M-59.21%
2013-12-31A$0.6 M18.03%
2012-12-31A$0.51 M-53.54%
2011-12-31A$1.1 M-31.94%
2010-12-31A$1.63 M-31.12%
2009-12-31A$2.36 M-29.16%
2008-12-31A$3.34 M-54.2%
2007-12-31A$7.29 M-43.89%
2006-12-31A$13 M0.79%
2005-12-31A$12.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$67.26 B 544,331.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$19.44 B 157,324.33%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$94.71 B 766,531.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$33.51 B 271,145.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$69.23 B 560,301.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$40.90 B 330,979.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$33.48 B 270,950.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A$95.83 M 675.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$23.98 B 194,056.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel